Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds.

Porous biodegradable silk scaffolds and human bone marrow derived mesenchymal stem cells (hMSCs) were used to engineer bone-like tissue in vitro. Two different scaffolds with the same microstructure were studied: collagen (to assess the effects of fast degradation) and silk with covalently bound RGD sequences (to assess the effects of enhanced cell attachment and slow degradation). The hMSCs were isolated, expanded in culture, characterized with respect to the expression of surface markers and ability for chondrogenic and osteogenic differentiation, seeded on scaffolds, and cultured for up to 4 weeks. Histological analysis and microcomputer tomography showed the development of up to 1.2-mm-long interconnected and organized bonelike trabeculae with cuboid cells on the silk-RGD scaffolds, features still present but to a lesser extent on silk scaffolds and absent on the collagen scaffolds. The X-ray diffraction pattern of the deposited bone corresponded to hydroxyapatite present in the native bone. Biochemical analysis showed increased mineralization on silk-RGD scaffolds compared with either silk or collagen scaffolds after 4 weeks. Expression of bone sialoprotein, osteopontin, and bone morphogenetic protein 2 was significantly higher for hMSCs cultured in osteogenic than control medium both after 2 and 4 weeks in culture. The results suggest that RGD-silk scaffolds are particularly suitable for autologous bone tissue engineering, presumably because of their stable macroporous structure, tailorable mechanical properties matching those of native bone, and slow degradation.

[1]  R. Harper,et al.  Measurement of Non-Crystalline Calcium Phosphate in Bone Mineral.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  L. Rosenberg.  Chemical basis for the histological use of safranin O in the study of articular cartilage. , 1971, The Journal of bone and joint surgery. American volume.

[3]  A. Lehninger,et al.  Atomic structure of intracellular amorphous calcium phosphate deposits. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Friedenstein.  Precursor cells of mechanocytes. , 1976, International review of cytology.

[5]  D. C. Sheehan,et al.  Theory and Practice of Histotechnology , 1980 .

[6]  L. Avioli,et al.  Matrix sialoprotein of developing bone. , 1983, The Journal of biological chemistry.

[7]  M. Glimcher,et al.  Failure to detect crystalline brushite in embryonic chick and bovine bone by X-ray diffraction. , 1984, Journal of ultrastructure research.

[8]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.

[9]  A. Friedenstein,et al.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers , 1987, Cell and tissue kinetics.

[10]  W. Butler,et al.  The nature and significance of osteopontin. , 1989, Connective tissue research.

[11]  L. Hench,et al.  CRC handbook of bioactive ceramics , 1990 .

[12]  J. Feijen,et al.  Relations between in vitro cytotoxicity and crosslinked dermal sheep collagens. , 1992, Journal of biomedical materials research.

[13]  R Langer,et al.  Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. , 1993, Journal of biomedical materials research.

[14]  P Rüegsegger,et al.  Non-invasive bone biopsy: a new method to analyse and display the three-dimensional structure of trabecular bone. , 1994, Physics in medicine and biology.

[15]  A I Caplan,et al.  The mesengenic process. , 1994, Clinics in plastic surgery.

[16]  M. Inamori,et al.  Industry , 1995, Encyclopedic Dictionary of Archaeology.

[17]  M. Tsukada,et al.  Attachment and growth of cultured fibroblast cells on silk protein matrices. , 1995, Journal of biomedical materials research.

[18]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[19]  J O Hollinger,et al.  Role of bone substitutes. , 1996, Clinical orthopaedics and related research.

[20]  M J Yaszemski,et al.  Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. , 1997, Journal of Biomedical Materials Research.

[21]  F. Lecanda,et al.  Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein‐2 , 1997, Journal of cellular biochemistry.

[22]  H Suh,et al.  Recent advances in biomaterials. , 1998, Yonsei medical journal.

[23]  A M Mackay,et al.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. , 1998, Tissue engineering.

[24]  M Elices,et al.  Silkworm silk as an engineering material , 1998 .

[25]  M J Lysaght,et al.  An economic survey of the emerging tissue engineering industry. , 1998, Tissue engineering.

[26]  D J Mooney,et al.  Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.

[27]  Robert Langer,et al.  Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation , 1999, The Lancet.

[28]  J. Zaia,et al.  The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). , 1999, Biochemical and biophysical research communications.

[29]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[30]  Gordana Vunjak-Novakovic,et al.  CHAPTER 13 – TISSUE ENGINEERING BIOREACTORS , 2000 .

[31]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[32]  M B McCarthy,et al.  Functionalized silk-based biomaterials for bone formation. , 2001, Journal of biomedical materials research.

[33]  R Langer,et al.  Selective differentiation of mammalian bone marrow stromal cells cultured on three-dimensional polymer foams. , 2001, Journal of biomedical materials research.

[34]  R. Cancedda,et al.  Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. , 2002, Tissue engineering.

[35]  Ivan Martin,et al.  Silk matrix for tissue engineered anterior cruciate ligaments. , 2002, Biomaterials.

[36]  David L. Kaplan,et al.  Spiderless spider webs , 2002, Nature Biotechnology.

[37]  David L Kaplan,et al.  Silk-based biomaterials. , 2003, Biomaterials.

[38]  M. Somerman,et al.  Bone Morphogenetic Protein-2 Inhibits Differentiation and Mineralization of Cementoblasts in vitro , 2003, Journal of dental research.

[39]  David L Kaplan,et al.  Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers. , 2003, Journal of biomedical materials research. Part A.

[40]  Gordana Vunjak-Novakovic,et al.  Bone Tissue Engineering Using Human Mesenchymal Stem Cells: Effects of Scaffold Material and Medium Flow , 2004, Annals of Biomedical Engineering.

[41]  Ivan Martin,et al.  Method for Quantitative Analysis of Glycosaminoglycan Distribution in Cultured Natural and Engineered Cartilage , 1999, Annals of Biomedical Engineering.

[42]  David L Kaplan,et al.  Porous 3-D scaffolds from regenerated silk fibroin. , 2004, Biomacromolecules.

[43]  Vassilios Sikavitsas,et al.  Tissue Engineering Bioreactors , 2006 .

[44]  M. Glimcher,et al.  Failure to detect an amorphous calcium-phosphate solid phase in bone mineral: A radial distribution function study , 1984, Calcified Tissue International.